About UsOrion BioScience is a biotechnology company developing two platforms to treat autoimmune diseases and autoimmune associated inflammation. Founded in 2012 as a spinout from the University of Kansas, and now located in Omaha, NE, Orion brings together a talented team, including decades of executive start-up experience in Silicon Valley in both private and public Biotech. The combination of ground-breaking technologies, a proven team, and a region ready to expedite preclinical efforts, uniquely positions Orion to reach value-inflection points rapidly and cost-effectively.
|
|
The Orion Approach
Orion BioScience Inc. is focused on developing two first-in-class therapeutic modalities to ameliorate the devastating effects of autoimmune diseases. We have invented two disruptive technologies to provide both immediate relief and a long-term solution for 100M+ people.
|
Orion's Exclusivity
Orion’s intellectual property includes significant know-how, issued US patents, and a global patent estate covering the both of our technology platforms, both of which have been exclusively licensed from the University of Kansas for all fields and territories.
|